CMT2A and mithocondria: an important scientific study from USA

malattia_ricerca_cmt

We wish to share this important American scientific study, whose results have been published on Science in April 2018, speaking about identification of a molecule that, by targeting the Mitofusin protein, is able to restore mitochondrial functions in mouse models of CMT2A. 

Thanks to the dear Sonia Lauth of CMT France for having brought this research to our attention.

Science. 2018 Apr 20;360(6386):336-341. doi: 10.1126/science.aao1785.

MFN2 agonists reverse mitochondrial defects in preclinicalmodels of Charcot-Marie-Tooth disease type 2A.

Rocha AG1, Franco A1, Krezel AM2, Rumsey JM1, Alberti JM1, Knight WC1, Biris N3, Zacharioudakis E3, Janetka JW2, Baloh RH4, Kitsis RN5, Mochly-Rosen D6, Townsend RR1, Gavathiotis E3, Dorn GW 2nd7.

Leave a Reply

Your email address will not be published. Required fields are marked *

Join our mailing list. Always stay up to date.